We also found evidence of colocalization of whole-blood CDKN1A expression, CAD, and breast cancer susceptibility at the CDKN1A locus and that whole-blood CDKN1A expression increased the risk of CAD but lowered the risk of breast cancer. Here, CDKN1A is linked to breast carcinoma.